Acute ischaemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: a case report

Research output: Contribution to journalCase reportContributedpeer-review

Contributors

  • Charlotte Zerna - , University Hospital Carl Gustav Carus Dresden (Author)
  • Michael Guenther - , University Hospital Carl Gustav Carus Dresden (Author)
  • Gunnar Folprecht - , University Cancer Centre Dresden, University Hospital Carl Gustav Carus Dresden (Author)
  • Volker Puetz - , Department of Neurology (Author)

Abstract

Vinorelbine is an important chemotherapeutic agent which is used in metastatic non-small cell lung cancer. Case reports have described the occurrence of acute cardiac ischaemic events as a side effect. It has not been established whether the suspected mechanisms for cardiac ischaemia might also cause other vascular events. We report about a 70-year-old male with metastatic non-small cell lung cancer who received vinorelbine as an outpatient. The patient presents with a cardiovascular risk profile. He was admitted to the hospital 3 days later with acute left-sided hemiplegia and hemianopia. Brain computed tomography (CT) demonstrated acute right hemispheric ischaemic stroke. Nine days after admission, the patient additionally suffered ST elevation myocardial infarction. A coronary angiogram demonstrated high grade stenosis of the right coronary artery treated with two bare-metal stents. Caution should be noted in patients who present with a cardiovascular risk profile as they might be vulnerable experiencing acute ischaemic events.

Details

Original languageEnglish
Pages (from-to)49-53
Number of pages5
JournalJournal of Chemotherapy
Volume29
Issue number1
Publication statusPublished - Feb 2017
Peer-reviewedYes

External IDs

researchoutputwizard legacy.publication#67138
researchoutputwizard legacy.publication#73587
PubMed 25579322
Scopus 84979582454
ORCID /0000-0002-9321-9911/work/142660325

Keywords

Sustainable Development Goals

Keywords

  • Aged, Antineoplastic Agents, Phytogenic/adverse effects, Carcinoma, Non-Small-Cell Lung/drug therapy, Comorbidity, Humans, Hypercholesterolemia/epidemiology, Hypertension/epidemiology, Lung Neoplasms/drug therapy, Male, Myocardial Infarction/chemically induced, Peripheral Arterial Disease/epidemiology, Risk Factors, Smoking, Stroke/chemically induced, Vinblastine/adverse effects, Vinorelbine